WO1994000587A3 - Attenuated equine herpesvirus-4 as live vaccine or recombinant vector - Google Patents

Attenuated equine herpesvirus-4 as live vaccine or recombinant vector Download PDF

Info

Publication number
WO1994000587A3
WO1994000587A3 PCT/GB1993/001355 GB9301355W WO9400587A3 WO 1994000587 A3 WO1994000587 A3 WO 1994000587A3 GB 9301355 W GB9301355 W GB 9301355W WO 9400587 A3 WO9400587 A3 WO 9400587A3
Authority
WO
WIPO (PCT)
Prior art keywords
equine herpesvirus
recombinant vector
live vaccine
attenuated equine
attenuated
Prior art date
Application number
PCT/GB1993/001355
Other languages
French (fr)
Other versions
WO1994000587A2 (en
Inventor
Marcello Riggio
David Edward Onions
Original Assignee
Univ Glasgow
Equine Virology Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Glasgow, Equine Virology Res Found filed Critical Univ Glasgow
Publication of WO1994000587A2 publication Critical patent/WO1994000587A2/en
Publication of WO1994000587A3 publication Critical patent/WO1994000587A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation

Abstract

The present invention is concerned with an attenuated Equine herpesvirus-4 vaccine. The attenuation is achieved by a mutation into a gene of Equine herpesvirus-4 defined in SEQ ID NO: 1. The invention also relates to a vector vaccine comprising an Equine herpesvirus-4 mutant having a foreign gene inserted into the Equine herpesvirus-4 genome.
PCT/GB1993/001355 1992-06-30 1993-06-29 Attenuated equine herpesvirus-4 as live vaccine or recombinant vector WO1994000587A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929213882A GB9213882D0 (en) 1992-06-30 1992-06-30 Live modified equine herpesvirus-4 vaccine
GB9213882.5 1992-06-30

Publications (2)

Publication Number Publication Date
WO1994000587A2 WO1994000587A2 (en) 1994-01-06
WO1994000587A3 true WO1994000587A3 (en) 1994-02-17

Family

ID=10717952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1993/001355 WO1994000587A2 (en) 1992-06-30 1993-06-29 Attenuated equine herpesvirus-4 as live vaccine or recombinant vector

Country Status (2)

Country Link
GB (1) GB9213882D0 (en)
WO (1) WO1994000587A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741696A (en) * 1992-08-07 1998-04-21 Syntro Corporation Recombinant equine herpesviruses
GB9626029D0 (en) 1996-12-14 1997-01-29 Univ Leeds EVH-1 vectors

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2185024A (en) * 1985-12-04 1987-07-08 Medical Res Council Peptide inhibitor of ribonucleotide reductase
WO1990002802A2 (en) * 1988-09-13 1990-03-22 Institute For Animal Health Limited Viral nucleotide sequences
EP0447303A1 (en) * 1990-03-12 1991-09-18 Rhone Merieux S.A. Recombinant herpes viruses, particularly for realization of vaccines, preparation process therefor, realized plasmids during this process and obtained vaccines
WO1992001045A1 (en) * 1990-07-06 1992-01-23 The University Court Of The University Of Glasgow Equine herpesvirus-4 tk- vaccine
EP0507179A2 (en) * 1991-04-05 1992-10-07 Bayer Ag Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2185024A (en) * 1985-12-04 1987-07-08 Medical Res Council Peptide inhibitor of ribonucleotide reductase
WO1990002802A2 (en) * 1988-09-13 1990-03-22 Institute For Animal Health Limited Viral nucleotide sequences
EP0447303A1 (en) * 1990-03-12 1991-09-18 Rhone Merieux S.A. Recombinant herpes viruses, particularly for realization of vaccines, preparation process therefor, realized plasmids during this process and obtained vaccines
WO1992001045A1 (en) * 1990-07-06 1992-01-23 The University Court Of The University Of Glasgow Equine herpesvirus-4 tk- vaccine
EP0507179A2 (en) * 1991-04-05 1992-10-07 Bayer Ag Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF GENERAL VIROLOGY vol. 69, no. 7, July 1988, pages 1575 - 1590 CULLINANE, A.A. ET AL. 'Characterization of the genome of Equine Herpesvirus 1 subtype 2' *
JOURNAL OF VIROLOGY vol. 63, no. 3, March 1989, pages 1123 - 1133 RIGGIO, M.P. ET AL. 'Identification and nucleotide sequence of the glycoprotein gB gene of Equine Herpesvirus 4' cited in the application *

Also Published As

Publication number Publication date
GB9213882D0 (en) 1992-08-12
WO1994000587A2 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
AU585126B2 (en) Recombinant herpes simplex viruses, vaccines and methods
MX9705727A (en) Amylase variants.
EP0994191A4 (en) System for expressing hyperthermostable protease
AU7228187A (en) Non-human carbonyl hydrolase mutants,DNA sequences and vectors encoding same and hosts transformed with vectors
AU2875492A (en) Recombinant core-streptavidin
WO1994024296A3 (en) Recombinant bovine herpesvirus type 1 vaccines
WO1995032731A3 (en) Immunogenic pharmaceuticals
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
AU4560693A (en) Non-shedding live herpesvirus vaccine
WO1994000587A3 (en) Attenuated equine herpesvirus-4 as live vaccine or recombinant vector
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
CA2099069A1 (en) Recombinant feline herpesvirus vaccine
SI0677584T1 (en) Stable mutants of D-N-alpha-carbamylase
WO1995012682A3 (en) Viral vector with bovine viral diarrhea virus (bvdv) antigens
CA2163081A1 (en) Thermoresistant Alpha-1-Antitrypsin Mutein
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
AU4702293A (en) Vector vaccines of recombinant feline herpesvirus
GR3033685T3 (en) Mutant interleukin 6 with improved biological activity over wild interleukin 6.
AU8043191A (en) Cloning and overexpression of glucose-6-phosphate dehydrogenase from Leuconostoc dextranicus
MX9603876A (en) Vacuolating toxin-deficient h. pylori and related methods.
EP1074624A4 (en) Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene
AU2705497A (en) Gene expression in monocytes and macrophages
WO1994004565A3 (en) Ipnv vaccine
ES2074965A1 (en) Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same.
CA2141422A1 (en) Recombinant equine herpesviruses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA GB JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA GB JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA